The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic
membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is …

The data were presented in abstract form at the 45th meeting of the American Society of
Nephrology, October 30-November 04 2012, San Diego, CA, USA. Circulating …

Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1)
have been demonstrated to be very specific for idiopathic membranous nephropathy (MN) …

Background Membranous nephropathy (MN) is the leading cause of nephrotic syndrome in
adults. Anti-M-type phospholipase A2 receptor (anti-PLA2R) antibodies are found in most …

The phospholipase A2 receptor (PLA2R) is the major target antigen (Ag) in idiopathic
membranous nephropathy (IMN). Recently, several types of immunoassay systems for anti …

Results 77.8% of iMN patients in our cohort had antibodies reactive with human PLA 2 R.
The antibody levels in these patients correlated strongly with both clinical status and …

Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults,
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …

Autoantibody against phospholipase A2 receptor (anti-PLA2R) is a sensitive and specific
biomarker of idiopathic membranous nephropathy (iMN), being found in approximately 70 …

Background Antibodies against M-type phospholipase A2 receptor (PLA2R) are serological
markers of disease activity in patients with idiopathic membranous nephropathy (iMN). To …

Background Circulating serum autoantibodies against the M-type phospholipase A2
receptor (PLA2R-AB) are a key biomarker in the diagnosis and monitoring of primary …